PATIENT INFORMATION LEAFLET

Similar documents
PATIENT INFORMATION LEAFLET

B. PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET

Package leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine

Pyrazinamide 500 mg Tablets (Macleods Pharmaceuticals Ltd), TB243. WHOPAR part 3 April 2014 Section 6 updated: May 2014 PACKAGE LEAFLET.

WHOPAR Part 3 March Zinc (as sulfate monohydrate) 20 mg Tablets (Macleods Pharmaceuticals Ltd), DI005 PACKAGE LEAFLET.

PATIENT INFORMATION LEAFLET. (company authorized English translation of the Patienteninformation approved by Swissmedic)

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER. Ethionamide 125 mg Dispersible Tablets 1

PATIENT INFORMATION LEAFLET

Package leaflet: Information for the user. Flutamid Stada 250 mg tablets Flutamide

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

PATIENT INFORMATION LEAFLET

PACKAGE LEAFLET: INFORMATION FOR THE USER Irbea 75 mg film-coated tablets Irbesartan

Package leaflet: Information for the user. Irprestan 150 mg film-coated tablets. Irprestan 300 mg film-coated tablets irbesartan

Package leaflet: Information for the user

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

XYZAL 5 MG FILM-COATED TABLET

Package leaflet: Information for the patient. [To be completed nationally] 10 mg film-coated tablets Ebastine

Irbenida 150 mg film-coated tablets; 300 mg film-coated tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium

Package Leaflet: Information for the User. Zomig Rapimelt 2.5 mg and 5 mg orodispersible tablets zolmitriptan

PATIENT INFORMATION LEAFLET

PACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride

PATIENT INFORMATION LEAFLET

Package leaflet: Information for the user. <PRODUCT NAME> 10 g powder for oral solution in sachet Macrogol 4000

PACKAGE LEAFLET: INFORMATION FOR THE USER. Cinfalair 4 mg chewable tablets

Package leaflet: Information for the user. Dalmevin 50 mg tablets Vildagliptin

Package leaflet: Information for the user. Famvir 125, 250 and 500 mg film-coated tablets famciclovir

1. WHAT OXCARBAZEPINE IS AND WHAT IT IS USED FOR

Package leaflet: Information for the patient. Vertigon 8 mg Tablets Vertigon 16 mg Tablets (betahistine dihydrochloride)

Package leaflet: Information for the user. Omnilax 10 g powder for oral solution, sachet. Macrogol 4000

Package leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine)

2 What you need to know before you take Naramig

SINGULAIR JUNIOR 5mg chewable tablets

PATIENT INFORMATION LEAFLET

Package leaflet: Information for the user

PATIENT INFORMATION LEAFLET

Package leaflet: Information for the user. Tianeptine 12.5 mg Film Coated Tablets (Tianeptine Sodium)

Package leaflet: Information for the user. Levonorgestrel 1.5 mg Tablet. levonorgestrel

PACKAGE LEAFLET: INFORMATION FOR THE USER Valaciclovir Bluefish 1000 mg film-coated tablets Valaciclovir

1. What Betahistine dihydrochloride tablets is and what it is used for

What is in this leaflet

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime

Sanomigran 500 microgram Tablets and Sanomigran 1.5 mg Tablets

Sibelium 5 mg Tablets flunarizine

AVIOMARIN 50 mg tablets

PATIENT INFORMATION LEAFLET. Calcichew* 500 mg Chewable Tablets calcium carbonate

PACKAGE LEAFLET: INFORMATION FOR THE USER

1. What Solpadol is and what it is used for

Package leaflet: Information for the user. Burinex 5 mg Tablets bumetanide

Package leaflet: Information for the patient. Flynise 5 mg Orodispersible Tablets desloratadine

Package leaflet: Information for the patient. SIRTURO 100 mg tablets Bedaquiline

PACKAGE LEAFLET. Page 1 of 6

Zinnat can also be used: to treat Lyme disease (an infection spread by parasites called ticks).

PATIENT INFORMATION LEAFLET

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER. THORDEL 4 mg chewable tablets montelukast

Package leaflet: Information for the patient. Valsartan 320 mg Film-coated Tablets valsartan

Package leaflet: Information for the user. Cinfalair 4 mg chewable tablets montelukast

HERNOVIR 200 mg tablets

Package leaflet: Information for the User Clarityn 10 mg tablets Loratadine

PATIENT INFORMATION LEAFLET

Irbenida H 150mg/12,5mg film-coated tablets

Package Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol

PACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin

Package Leaflet: Information for the User. Clonamox 125 mg/5 ml Powder for Oral Suspension Clonamox 250 mg/5 ml Powder for Oral Suspension

Package leaflet: Information for the user. Resolor 1 mg film-coated tablets Resolor 2 mg film-coated tablets prucalopride

PATIENT INFORMATION LEAFLET

PACKAGE LEAFLET: INFORMATION FOR THE USER Histabentine 8 mg/16 mg tablets. Betahistine dihydrochloride

Package leaflet: Information for the user. Finasterid Actavis 5 mg film coated tablets. Finasteride

Package leaflet: Information for the user. Entecavir Alvogen 0,5 mg filmomhulde tabletten Entecavir Alvogen 1 mg filmomhulde tabletten Entecavir

Atrosan Devil s Claw film-coated tablets

PATIENT INFORMATION LEAFLET DYNARB RANGE

2 What you need to know before you take Zantac

PATIENT INFORMATION LEAFLET AMLOC RANGE

Package Leaflet: Information for the User

Package leaflet: Information for the patient. Dexametason Abcur 4 mg tablets. Dexamethasone

Package leaflet: Information for the user. Fluvastatin

Package leaflet: Information for the user. Zomig Rapimelt 2.5 mg orodispersible tablets zolmitriptan

PATIENT INFORMATION LEAFLET

Package leaflet: Information for the patient

Package leaflet: Information for the user. Cetiristad 10 mg film-coated tablets Cetirizine dihydrochloride

Read this entire leaflet carefully before you start taking DYNA BEZAFIBRATE. If you have further questions, please ask your doctor or your pharmacist.

Some general information on hepatitis A infection is given at the end of this leaflet.

Package leaflet: Information for the patient. Felodipin AstraZeneca 10 mg prolonged-release tablets. felodipine

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets

Package leaflet: Information for the user. Lycimor 300 mg Hard Capsules Lymecycline (equivalent to 300mg of tetracycline base)

Transcription:

PATIENT INFORMATION LEAFLET Page 1 of 6

PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Artefan Dispersible 20/120 * Artemether/Lumefantrine 20mg/120mg Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, healthcare provider or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor, healthcare provider or pharmacist. This includes any possible side effects not listed in this leaflet. What is in this leaflet: 1. What Artefan Dispersible 20/120 is and what it is used for 2. What you need to know before you take Artefan Dispersible 20/120 3. How to take Artefan Dispersible 20/120 4. Possible side effects 5. How to store Artefan Dispersible 20/120 6. Contents of the pack and other information 1. WHAT ARTEFAN DISPERSIBLE 20/120 IS AND WHAT IT IS USED FOR This medicine is an antimalarial. It is used to treat a certain type of malaria infection in adults and children who weigh at least 5 kg. Artefan Dispersible 20/120 contains two antimalarial drugs, artemether and lumefantrine in fixed, which work together to kill the malaria parasite (a tiny organism that is found inside the red blood cells). Your doctor has found that you have malaria and so has prescribed Artefan Dispersible 20/120. It is indicated only for the treatment of so called uncomplicated malarial attacks due to Plasmodium falciparum (a particular type of malaria parasite) against which the medicine is active. For complete cure it is important that you complete the prescribed as advised by your doctor, pharmacist or health care worker. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE ARTEFAN DISPERSIBLE 20/120 Do not take Artefan Dispersible 20/120: - if you are hypersensitive (allergic) to artemether, lumefantrine, or any of the other ingredients of Artefan Dispersible 20/120 (see section 6, What Artefan Dispersible 20/120 contains). Warnings and precautions If you are pregnant, you must tell your doctor or health care provider. Artefan Dispersible 20/120 should only be used in pregnancy if it is considered absolutely necessary (see below Pregnancy and breast-feeding). * Trade names are not prequalified by WHO. This is under local drug regulatory authority s responsibility. Throughout this WHOPAR the proprietary name is given as an example only. Page 2 of 6

Artefan Dispersible 20/120 can change your electrical recording of the heart (electrocardiogram, ECG,). Therefore, before taking, Artefan Dispersible 20/120, inform your doctor of health care provider if you have: any condition with certain abnormal ECG changes a salt imbalance in the blood, especially low concentrations of potassium in the blood (hypokalaemia) which are currently not corrected by treatment. a very slow heart rate (bradycardia) a weak heart (heart failure) a history of abnormal heart rhythms (arrhythmias) Also, inform your doctor or health care provider: if you are taking any medicine that lowers your blood potassium levels. if you are taking other medicines that result in certain abnormal ECG changes (see below, Other medicines and Artefan Dispersible 20/120). If you experience palpitations or an irregular heartbeat during treatment, you should tell your doctor immediately. He/she may wish to perform an ECG. The use of Artefan Dispersible 20/120 has not been investigated in patients with kidney or liver disease. If you have any such condition, you should inform your doctor or health care provider before taking Artefan Dispersible 20/120. Artefan Dispersible 20/120 should not be used in patients with severe malaria for malaria prophylaxis or in combination with other drugs against malaria, unless your doctor or health care provider considers this appropriate in your particular case. You should inform your doctor or health care provider about all malaria medicines that you have taken the last months, as the appropriateness of using Artefan Dispersible 20/120 may depend on this. Artefan Dispersible 20/120 may lower the effects of hormonal contraceptives. Therefore a different or an additional method of contraception (e.g. condoms, intra-uterine device, pessary) should be used during treatment with Artefan Dispersible 20/120. It is important that your doctor or health care provider knows about all your symptoms, even when you think they are not related to malaria infection. Other medicines and Artefan Dispersible 20/120 It is important that you tell your doctor, health care provider or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. These may affect the action of Artefan Dispersible 20/120, or Artefan Dispersible 20/120 may affect their action. Side effects of either medicine may become worse and/or the medicines may become less effective. Especially tell your doctor or health care provider if you take or have recently taken: Any other medicines to treat or prevent malaria Medicines for your heart Antipsychotic medicines (for treatment of abnormal condition of the mind) Antidepressants (medication to alleviate mood disorders) Antibiotics Antihistamines (for treatment of, e.g., allergies) Cisapride (a medicine for improving gastric motility) Medicines to treat HIV infection Medicines against fungal infection Hormonal methods of birth control (for example birth control pills or contraceptive patch) Page 3 of 6

Artefan Dispersible 20/120 with food and drink Artefan Dispersible 20/120 should be taken with food or a milky drink. Pregnancy and breast-feeding Pregnancy Do not use this drug during pregnancy without medical advice. This is particularly important during the first 3 months of pregnancy. Breast-feeding Breast-feeding can be considered medical advice. Driving and using machines Artefan Dispersible 20/120 may cause dizziness and fatigue. If you feel dizzy or fatigued while taking Artefan Dispersible 20/120, do not drive and do not use any tools or machines. Artefan Dispersible 20/120 contains aspartame Artefan Dispersible 20/120 contains aspartame, a source of phenylalanine, which may be harmful for people with phenylketonuria. 3. HOW TO TAKE ARTEFAN DISPERSIBLE 20/120 Artefan Dispersible 20/120 should always be taken exactly as described by the doctor or health care provider. You should check with your doctor, health care provider or pharmacist if you are not sure. Dispersible tablets are for oral administration. Each of the dispersible tablet(s) should be completely dispersed in a small amount of water (approximately 10 ml per tablet). Stir gently and administer immediately to the patient. Rinse the glass with an additional small amount of water (approximately 10 ml) and give immediately to the patient. The of Artefan Dispersible 20/120 is decided on the basis of your or your child s body weight. Number of Artefan Dispersible 20/120 tablets for treatment according to weight bands Weight range Immediately diagnosis/ onset of symptoms Time Day 1 Day 2 Day 3 8 hours from 5kg up to 15kg From 15kg up to 25kg From 25kg up to 35kg From 35kg (or 12 years of age) 1 tablet 1 tablet 1 tablet 1 tablet 1 tablet 1 tablet 2 tablets 2 tablets 2 tablets 2 tablets 2 tablets 2 tablets 3 tablets 3 tablets 3 tablets 3 tablets 3 tablets 3 tablets 4 tablets 4 tablets 4 tablets 4 tablets 4 tablets 4 tablets Page 4 of 6

The first should be followed by a second 8 hours. The following two days the s of Artefan Dispersible 20/120 should be taken apart. Artefan Dispersible 20/120 should be taken with food or a milky drink. If you are unable to tolerate food, Artefan Dispersible 20/120 should still be administered, but your body may take up less of the medicine. If you vomit within 1 hour of taking the medication, you should repeat the. If you take more Artefan Dispersible 20/120 than you should If you take too many tablets, you may develop an abnormal heartbeat. Immediately contact your doctor, health care provider or the nearest hospital emergency department for further advice. If you forget to take Artefan Dispersible 20/120 Try to make sure that you do not miss any. However, if you do forget a, take the missed as soon as you realise that you have forgotten it. Then take the next the prescribed interval. Do not take a double to make up for a forgotten tablet. Make sure you take all six s of this regimen. If you stop taking Artefan Dispersible 20/120 You should keep taking the medicine for as long as your doctor has ordered, even if you are feeling better. If you stop the medicine too soon, the infection may not be completely cured. If you have any further questions on the use of this product, ask your doctor or health care provider or pharmacist. 4. POSSIBLE SIDE EFFECTS Like all medicines, Artefan Dispersible 20/120 can cause side effects, although not everybody gets them. When treating malaria, it is not always possible to differentiate between unwanted effects caused by Artefan Dispersible 20/120, and those caused by any other medicines you may be taking at the same time. For this reason, it is important that you inform the doctor or health care provider of any change in your health. The following side effects have been reported in patients treated with Artefan Dispersible 20/120: The most commonly reported side effects (greater than 1 in every 10 patients treated) include headache, dizziness, feeling sick, vomiting, abdominal pain, loss of appetite, palpitations, pain in muscles and joints, fatigue and disturbed sleep. Commonly (greater than 1 in every 100 patients treated) reported side effects include alterations to the electrocardiogram (ECG), tingling in hands and feet, problems with walking, cough, diarrhoea, itching, rash and insomnia. Uncommon side effects (greater than 1 in every 1000 patients treated but less than 1 in 100): involuntary muscle jerks, coordination disturbances, altered liver function tests and drowsiness. The following side effects have been reported in patients treated with Artefan Dispersible 20/120. However, frequency estimates for these effects are not available: hypersensitivity reaction, hives, rapid swelling of the face and throat (angioedema). A similar side effect profile was reported for children If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, health care provider or pharmacist as soon as possible. Page 5 of 6

5. HOW TO STORE ARTEFAN DISPERSIBLE 20/120 Keep this medicine out of the sight and reach of children. Do not store above 30 C. Store in the original package in the outer carton. Do not use Artefan Dispersible 20/120 the expiry date which is stated on the blister and the outer packaging EXP. The expiry date refers to the last day of that month. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment. 6. CONTENTS OF THE PACK AND OTHER INFORMATION What Artefan Dispersible 20/120 contains The active ingredients are: 20 mg artemether and 120 mg lumefantrine The other ingredients are: Aspartame, Capsaroma flavour orange DC 116 PH, Capsaroma flavour peppermint DC 117 PH, colloidal anhydrous silica, crospovidone, low-substituted hydroxypropyl cellulose, magnesium stearate, mannitol and microcrystalline cellulose. What Artefan Dispersible 20/120 looks like and contents of the pack Artefan Dispersible 20/120 is a yellow coloured, circular, flat bevelled edge, dispersible tablet. Artefan Dispersible 20/120 is provided in clear PVC/PVdC-aluminium blister packs. Each blister has either 6 or 12 tablets and each pack contains either one or 30 such blisters. Supplier Supplier Ajanta Pharma Ltd. Ajanta House Charkop Kandivli (West) Mumbai 400 067, India Tel: +9122 66061000 Email: info@ajantapharma.com Manufacturer Manufacturer Ajanta Pharma Limited B-4-5-6, MIDC Industrial Area Paithan, Aurangabad, 431128 Dist: Aurangabad Maharashtra, India. Tel: +91-2431- 664000 Fax: +91-2431- 664100 For any information about this medicinal product, please contact the supplier. This leaflet was last approved in August 2013. Detailed information on this medicine is available on the World Health Organization (WHO) web site: http://www.who.int/prequal/. Page 6 of 6